Skip to main content
. Author manuscript; available in PMC: 2023 Sep 18.
Published in final edited form as: Curr Eye Res. 2021 Mar 24;46(10):1525–1530. doi: 10.1080/02713683.2021.1899246

Figure 2.

Figure 2.

STC-1 reduces IOP in the DBA/2J mouse. (a) Complete experiment displayed in a longitudinal fashion. (b) At experimental days 6–8, STC-1 lowered IOP compared to PBS (n = 10). (c) Representative toluidine blue-stained sections of 14-month old DBA/2J mice treated with PBS in one eye and STC-1 in the fellow eye show angle closure with synechiae formation (asterisk), iris atrophy (arrow), and pigment-laden macrophages (chevron). ***P < .001. Error bars represent mean ± standard deviation.